Swedencare AB (SWDCF)
2.30
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Swedencare Net Income (Quarterly) : 2.531M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.531M |
| March 31, 2026 | 1.936M |
| December 31, 2025 | 1.743M |
| September 30, 2025 | 2.332M |
| June 30, 2025 | -0.7138M |
| March 31, 2025 | 2.239M |
| December 31, 2024 | 2.208M |
| September 30, 2024 | 2.303M |
| June 30, 2024 | 1.955M |
| March 31, 2024 | 2.895M |
| December 31, 2023 | -1.219M |
| September 30, 2023 | 3.524M |
| June 30, 2023 | 1.546M |
| March 31, 2023 | 1.648M |
| December 31, 2022 | 1.472M |
| September 30, 2022 | 0.3603M |
| June 30, 2022 | 6.123M |
| March 31, 2022 | 1.574M |
| December 31, 2021 | 2.220M |
| September 30, 2021 | 1.248M |
| June 30, 2021 | 1.808M |
| March 31, 2021 | 1.062M |
| December 31, 2020 | 0.858M |
| Date | Value |
|---|---|
| September 30, 2020 | 1.635M |
| June 30, 2020 | 0.5316M |
| March 31, 2020 | 0.8718M |
| December 31, 2019 | 0.5949M |
| September 30, 2019 | 0.9255M |
| June 30, 2019 | 0.7207M |
| March 31, 2019 | 0.9273M |
| December 31, 2018 | 0.6348M |
| September 30, 2018 | 0.7781M |
| June 30, 2018 | 0.6699M |
| March 31, 2018 | 0.5918M |
| December 31, 2017 | 0.6199M |
| September 30, 2017 | 0.5481M |
| June 30, 2017 | 0.245M |
| March 31, 2017 | 0.5869M |
| December 31, 2016 | 0.068M |
| September 30, 2016 | 0.38M |
| June 30, 2016 | 0.3205M |
| March 31, 2016 | 0.3892M |
| December 31, 2015 | -0.0338M |
| September 30, 2015 | 0.2741M |
| June 30, 2015 | 0.3375M |
| March 31, 2015 | 0.216M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Orexo AB | -10.95M |
| Camurus AB | 25.72M |
| Moberg Pharma AB | -0.3504M |
| Infant Bacterial Therapeutics AB | -2.509M |
| AstraZeneca PLC | 3.076B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 71.55M |
| Total Expenses (Quarterly) | 69.02M |
| EPS Diluted (Quarterly) | 0.0158 |
| Enterprise Value | 540.81M |
| Gross Profit Margin (Quarterly) | 7.63% |
| Profit Margin (Quarterly) | 3.54% |
| Earnings Yield | 2.32% |
| Operating Earnings Yield | 5.09% |
| Normalized Earnings Yield | 2.322 |